These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30465763)

  • 1. Getting Too Old Too Quickly for Their Job: Senescent Glial Cells Promote Neurodegeneration.
    Gosselin D; Rivest S
    Neuron; 2018 Nov; 100(4):777-779. PubMed ID: 30465763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there roles for brain cell senescence in aging and neurodegenerative disorders?
    Tan FC; Hutchison ER; Eitan E; Mattson MP
    Biogerontology; 2014 Dec; 15(6):643-60. PubMed ID: 25305051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and the aging brain: are senescent microglia the key to neurodegeneration?
    Angelova DM; Brown DR
    J Neurochem; 2019 Dec; 151(6):676-688. PubMed ID: 31478208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.
    Bussian TJ; Aziz A; Meyer CF; Swenson BL; van Deursen JM; Baker DJ
    Nature; 2018 Oct; 562(7728):578-582. PubMed ID: 30232451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageing, Cellular Senescence and Neurodegenerative Disease.
    Kritsilis M; V Rizou S; Koutsoudaki PN; Evangelou K; Gorgoulis VG; Papadopoulos D
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
    Ling H
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2018 Dec; 21(6):572-579. PubMed ID: 30489222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuro-glial-vascular interrelations in genomic instability symptoms.
    Barzilai A
    Mech Ageing Dev; 2011 Aug; 132(8-9):395-404. PubMed ID: 21689674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cellular senescence in aging through the prism of Koch-like criteria.
    Yanai H; Fraifeld VE
    Ageing Res Rev; 2018 Jan; 41():18-33. PubMed ID: 29106993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial epigenetics in neuroinflammation and neurodegeneration.
    Staszewski O; Prinz M
    Cell Tissue Res; 2014 Jun; 356(3):609-16. PubMed ID: 24652504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticobasal degeneration: selected developments.
    Lang AE
    Mov Disord; 2003 Sep; 18 Suppl 6():S51-6. PubMed ID: 14502656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila.
    Kretzschmar D; Tschäpe J; Bettencourt Da Cruz A; Asan E; Poeck B; Strauss R; Pflugfelder GO
    Glia; 2005 Jan; 49(1):59-72. PubMed ID: 15390099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.
    Dabir DV; Trojanowski JQ; Richter-Landsberg C; Lee VM; Forman MS
    Am J Pathol; 2004 Jan; 164(1):155-66. PubMed ID: 14695329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Senescence, Neurological Function, and Redox State.
    Maciel-Barón LÁ; Moreno-Blas D; Morales-Rosales SL; González-Puertos VY; López-Díazguerrero NE; Torres C; Castro-Obregón S; Königsberg M
    Antioxid Redox Signal; 2018 Jun; 28(18):1704-1723. PubMed ID: 28467755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
    Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.